AB
OBIO icon

Amalgamated Bank’s Orchestra BioMed OBIO Stock Holding History

Amalgamated Bank’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-847
Closed -$4K – 3099
2025
Q1 		$4K Buy
847
+335
+65% +$1.67K ﹤0.01% 2733
2024
Q4 		$2K Hold
512
– – ﹤0.01% 2914
2024
Q3 		$3K Hold
512
– – ﹤0.01% 2889
2024
Q2 		$4K Buy
512
+371
+263% +$2.15K ﹤0.01% 2871
2024
Q1 		$1K Sell
141
-1,268
-90% -$8.59K ﹤0.01% 2921
2023
Q4 		$13K Buy
1,409
+774
+122% +$5.28K ﹤0.01% 2813
2023
Q3 		$6K Hold
635
– – ﹤0.01% 2963
2023
Q2 		$4K Buy
+635
New +$9.63K ﹤0.01% 3006

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Bank's OBIO Position: Q2 2025 in Review

Amalgamated Bank sold out of Orchestra BioMed (OBIO) in Q2 2025, closing a stake of 847 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in OBIO in Q2 2023 and held it in 8 quarters. The position peaked at $13K in Q4 2023. 59 funds tracked by Wall St. Rank hold OBIO as of Q2 2025.

  • Amalgamated Bank reported no remaining Orchestra BioMed position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 847 Orchestra BioMed shares in Q2 2025, an estimated $4K.
  • Amalgamated Bank first reported a position in Orchestra BioMed in Q2 2023 and held it in 8 quarters.
  • Amalgamated Bank's Orchestra BioMed position peaked at $13K in Q4 2023.
  • 59 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.